BioCentury | Feb 16, 2017
Clinical News

Cotsiranib: Ph IIa started

...STP705 ) Business: Dermatology Molecular target: Transforming growth factor (TGF) beta 1 (TGFB1) mRNA ; Cyclooxygenase-2 (COX-2) mRNA...
...size of scar and safety Status: Phase IIa started Milestone: Complete Phase IIa (4Q17) Alicia Parker STP705 Sirnaomics Inc. Cyclooxygenase-2 (COX-2) mRNA Cotsiranib Transforming...
Items per page:
1 - 1 of 1